Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 4/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 3/20 | 0.37 |
| ▸ | IDO1 | P14902 | 1/20 | 0.37 |
| ▸ | METAP2 | P50579 | 1/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | CASP3 | P42574 | 1/20 | 0.35 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.35 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.35 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL47202 | 0.84 | — | — | |
| SCHEMBL28184041 | 0.82 | — | — | |
| Ammonia Solution, Strong SCHEMBL27712725 | 0.82 | — | — | |
| SCHEMBL27700371 | 0.82 | — | — | |
| Phosphine SCHEMBL27520992 | 0.82 | — | — | |
| Water SCHEMBL28190991 | 0.82 | — | — | |
| SCHEMBL27859705 | 0.82 | — | — | |
| Bromide SCHEMBL15820960 | 0.82 | — | — | |
| SCHEMBL27869458 | 0.82 | — | — | |
| SCHEMBL27721690 | 0.82 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2298737-B1 | Indole compounds and organic light-emitting device including the same | SAMSUNG DISPLAY CO LTD (KR) | 2017-05-10 | — | — | EP | disclosed |
| US-8399880-B2 | Heteroarylamine compound and organic light-emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2013-03-19 | — | — | US | disclosed |
| US-8283057-B2 | Heteroarylamine compound and organic light-emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2012-10-09 | — | — | US | disclosed |
| EP-2298740-A1 | 1-H-benzo[g]indole compounds and organic lightemitting device including the same | Samsung Mobile Display Co., Ltd. (KR) | 2011-03-23 | — | — | EP | disclosed |
| EP-2298737-A1 | Indole compounds and organic light-emitting device including the same | Samsung Mobile Display Co., Ltd. (KR) | 2011-03-23 | — | — | EP | disclosed |
| US-20110049484-A1 | HETEROARYLAMINE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2011-03-03 | — | — | US | disclosed |
| US-20110049494-A1 | HETEROARYLAMINE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2011-03-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110049494-A1 | HETEROARYLAMINE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | INMT, TYR, HTT | ACHE 56/4885ALDH1A1 1062/4885MAPK1 3616/4885 |
| US-20110049484-A1 | HETEROARYLAMINE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | INMT, TYR, HTT | ACHE 56/4885ALDH1A1 1062/4885MAPK1 3616/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.